CMMBVSGTBP• 28 Days (Normalized)
CMMB vs GTBP (Chemomab Therapeutics Ltd. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-38.83%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-38.83 pts
GTBP outperforming by 38.83 percentage points
CMMBGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | CMMB Price | CMMB Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -38.83% | $- | - | |
| Sep 28, 2026 | $1.64 | -39.93% | $- | - | |
| Sep 25, 2026 | $2.16 | -20.88% | $- | - | |
| Sep 24, 2026 | $2.20 | -19.41% | $- | - | |
| Sep 23, 2026 | $2.28 | -16.48% | $7.10 | +2356.75% | -2373.23% |
| Sep 22, 2026 | $2.51 | -8.06% | $- | - | |
| Sep 21, 2026 | $2.48 | -9.16% | $7.18 | +2384.43% | -2393.59% |
| Sep 18, 2026 | $2.61 | -4.40% | $7.16 | +2377.51% | -2381.91% |
| Sep 17, 2026 | $2.80 | +2.56% | $7.49 | +2491.70% | -2489.14% |
| Sep 16, 2026 | $2.65 | -2.93% | $7.81 | +2602.42% | -2605.35% |
| Sep 15, 2026 | $2.47 | -9.52% | $9.00 | +3014.19% | -3023.71% |
| Sep 14, 2026 | $2.45 | -10.26% | $11.63 | +3924.22% | -3934.48% |
| Sep 11, 2026 | $2.58 | -5.49% | $8.61 | +2879.24% | -2884.73% |
| Sep 10, 2026 | $2.60 | -4.76% | $6.18 | +2038.41% | -2043.17% |
| Sep 09, 2026 | $2.69 | -1.47% | $5.98 | +1969.20% | -1970.67% |
Page 1 of 2